NLRC4 and hematoma: Just as listed in Table 5, patients with poor prognosis, in comparison to other remainders, were likely to show markedly rising percentage of NLRC4 levels >363.2 pg/ml (P < 0.05), and were prone to display substantially increased NIHSS scores, hematoma volume, blood leucocyte count and serum C-reactive protein levels (all P < 0.05).